Cargando…
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring
The widespread clinical use of the cytostatic doxorubicin together with the induction of chronic cardiomyopathy necessitates the conduct of further pharmacokinetic trials. Novel analytical technologies suitable for point-of-care applications can facilitate drug level analyses but might be prone to i...
Autores principales: | Siebel, Christian, Lanvers-Kaminsky, Claudia, Würthwein, Gudrun, Hempel, Georg, Boos, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596548/ https://www.ncbi.nlm.nih.gov/pubmed/33122763 http://dx.doi.org/10.1038/s41598-020-75662-w |
Ejemplares similares
-
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
por: Siebel, Christian, et al.
Publicado: (2020) -
Towards a Model-Based Dose Recommendation for Doxorubicin in Children
por: Völler, Swantje, et al.
Publicado: (2016) -
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
por: Siebel, Christian, et al.
Publicado: (2021) -
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data
por: Würthwein, Gudrun, et al.
Publicado: (2021) -
Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
por: Harahap, Yahdiana, et al.
Publicado: (2020)